Work

Targeting CD11b+ Myeloid Cell Recruitment Therapeutically Treats Lupus Nephritis via Reductions in Soluble Urokinase Plasminogen Activator Receptor (suPAR) and C-C Motif Ligand 2 (CCL2) Levels

Year: 2025

Type: article

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.2025jq1mwqv8

Authors: Xiaobo Li, Billy Nguyen, Nishant Ranjan, Santiago Balza Pineda, Mohamed A. Youssef, Brenna Knott, David Changli Wei, Darlah M. Lopez-Rodriguez, Shikha Wadhwani, Salim Hayek, Roberto I. Vazquez-Padron, Hafeez Faridi, Jochen Reiser, Timothy B. Niewold, Vineet Gupta

Institutions: The University of Texas Medical Branch at Galveston, Rush University, University of Miami, Chicago State University, Hospital for Special Surgery

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416066632

FWCI:

Cites:

Cited by:

Related to: